Akèy › Sipwa › Tennessee › Memphis
Etid klinik pou Sipwa nan Memphis, TN
8 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Ap rekriteFaz 3
- LifeDoc Health, Memphis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Ap rekriteFaz 3
- Gastroenterology Center Of The Midsouth, Cordova · 15 mi lwen
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ap rekriteFaz 3
- Gastroenterology Center Of The Midsouth, Cordova · 15 mi lwen
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Stern Cardiovascular Foundation Inc, Germantown · 14 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 3
- AURORA-1 Clinical Site, Memphis
- AURORA-1 Clinical Site, Olive Branch · 18 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Memphis
- AURORA-2 Clinical Site, Olive Branch · 18 mi lwen
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Ap rekriteFaz 3
- Olive Branch Family Medical Center, Olive Branch · 18 mi lwen
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailea Clinical Site, Memphis
Etid Sipwa nan lòt vil
- San Antonio, TX34 etid
- Houston, TX33 etid
- Chicago, IL28 etid
- Orlando, FL27 etid
- Las Vegas, NV23 etid
- Miami, FL23 etid
- Atlanta, GA20 etid
- Dallas, TX20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
Lòt etid nan Memphis
- Kansè (tout kalite)31 etid
- Kansè Poumon ki pa ti selil23 etid
- Kansè nan tete22 etid
- Kansè poumon18 etid
- Maladi selil fòs18 etid
- Leksemi limfoblastik egi16 etid
- Leksemi mieloïd egi15 etid
- Ensifizyans kadyak13 etid
- Kansè kolorektal11 etid
- Sarkom tisi mou11 etid
- Melanom11 etid
- Kansè pwostat11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.